focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

30 Jun 2021 07:00

RNS Number : 5532D
Allied Minds PLC
30 June 2021
 

30 June 2021

 

Allied Minds

 

Transaction in own shares

 

Allied Minds plc (AIM:ALM, 'Allied Minds' or 'the Company') announces that, in accordance with the terms of its share buyback programme announced on 23 June 2021 ("Share Buyback Programme"), the Company purchased the following number of its Ordinary Shares of £0.01 each ("Ordinary Shares") through Numis Securities Limited. The Ordinary Shares purchased will be cancelled.

 

Date of purchase:

 29 June 2021

Aggregate number of Ordinary Shares purchased:

123,563

Lowest price paid per share (GBp):

20.600

Highest price paid per share (GBp):

20.800

Average price paid per share (GBp):

20.6621

 

Following the purchase of these shares, the remaining number of Ordinary Shares in issue will be 241,563,608 (excluding treasury shares), and the Company hold no Ordinary Shares in treasury. Therefore, the total voting rights in the Company will be 241,563,608. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the table below contains detailed information of the individual trades made by Numis Securities Limited as part of the Share Buyback Programme.

 

Schedule of Purchases - Individual Transactions

 

Number of ordinary shares purchased

Transaction price(GBp share)

Time of transaction (UK Time)

Transaction reference number

Trading venue

2500

20.72

09:33:08

00052422793TRLO0

LSE

7738

20.80

13:52:10

00052437620TRLO0

LSE

1000

20.80

14:48:53

00052442311TRLO0

LSE

5646

20.60

16:21:05

00052451611TRLO0

LSE

4861

20.60

16:21:05

00052451612TRLO0

LSE

5189

20.60

16:21:05

00052451618TRLO0

LSE

9255

20.60

16:21:06

00052451626TRLO0

LSE

6669

20.60

16:21:06

00052451627TRLO0

LSE

777

20.60

16:21:06

00052451628TRLO0

LSE

954

20.60

16:21:06

00052451629TRLO0

LSE

1774

20.60

16:21:09

00052451638TRLO0

LSE

1869

20.60

16:22:07

00052451763TRLO0

LSE

5567

20.60

16:22:20

00052451782TRLO0

LSE

1953

20.60

16:22:26

00052451790TRLO0

LSE

933

20.60

16:22:26

00052451789TRLO0

LSE

5486

20.60

16:22:26

00052451791TRLO0

LSE

1977

20.60

16:22:26

00052451792TRLO0

LSE

5389

20.60

16:22:26

00052451793TRLO0

LSE

51112

20.71

16:23:53

00052451954TRLO0

LSE

1098

20.60

16:24:52

00052452083TRLO0

LSE

1816

20.60

16:27:51

00052452496TRLO0

LSE

 

 

For more information, please contact:

 

Allied Minds plc

c/o Instinctif Partners

Harry Rein

Instinctif

alliedminds@instinctif.com

Tim Linacre / Rozi Morris / Hannah Campbell

 

 

About Allied Minds

Allied Minds plc is an IP commercialisation company focused on early stage company development within the technology sector. With origination relationships that span US federal laboratories, universities, and leading US corporations, Allied Minds historically created, and now operates and funds, a portfolio of companies to generate long-term value for its investors and stakeholders. Based in Boston, Allied Minds supports its businesses with capital, management, expertise and shared services. For more information, please visit www.alliedminds.com.

 

 

###

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGZGZVNLFGMZM
Date   Source Headline
31st Jan 20173:55 pmRNSTotal Voting Rights
30th Jan 201712:02 pmRNSPrice Monitoring Extension
3rd Jan 20172:48 pmRNSHolding(s) in Company
3rd Jan 20172:11 pmRNSTotal Voting Rights
13th Dec 20167:00 amRNSFormation of Signature Medical, Inc.
9th Dec 20165:04 pmRNSHolding(s) in Company
7th Dec 20164:34 pmRNSHolding(s) in Company
6th Dec 20165:05 pmRNSHolding(s) in Company
6th Dec 20165:04 pmRNSHolding(s) in Company
2nd Dec 20167:00 amRNSResults of equity placing
1st Dec 20164:50 pmRNSProposed Equity Placing
23rd Nov 20167:00 amRNSHawkEye 360 Raises $11m in Series A Financing
21st Nov 20167:00 amRNSFormation of Vatic Materials, Inc.
18th Nov 20163:15 pmRNSBlock Listing Six Monthly Return
11th Nov 20165:17 pmRNSHolding(s) in Company
24th Oct 20167:00 amRNSPrecision Biopsy Raises $5.0 Million
17th Oct 201612:07 pmRNSSecond Price Monitoring Extn
17th Oct 201612:02 pmRNSPrice Monitoring Extension
29th Sep 20167:00 amRNSAllied Minds & GE Ventures Form Strategic Alliance
8th Sep 201612:02 pmRNSPrice Monitoring Extension
31st Aug 20165:11 pmRNSTotal Voting Rights
25th Aug 20167:00 amRNSHalf-year Report
22nd Aug 20167:00 amRNSAllied Minds Secures $20m Debt Facility from SVB
22nd Aug 20167:00 amRNSAllied Minds' Subsidiary ABLS II Raises $15m
1st Aug 20167:00 amRNSSciFluor Enters Clinical Trial Stage
29th Jul 201610:30 amRNSTotal Voting Rights
13th Jul 201610:02 amRNSDirector/PDMR Shareholding
13th Jul 201610:01 amRNSDirector/PDMR Shareholding
13th Jul 201610:01 amRNSDirector/PDMR Shareholding
13th Jul 201610:00 amRNSDirector/PDMR Shareholding
7th Jul 20167:00 amRNSLong Term Incentive Plan - Listing Application
30th Jun 20167:00 amRNSTotal Voting Rights
22nd Jun 20164:41 pmRNSSecond Price Monitoring Extn
22nd Jun 20164:35 pmRNSPrice Monitoring Extension
14th Jun 20162:38 pmRNSDirector/PDMR Shareholding
13th Jun 20165:18 pmRNSDirector/PDMR Shareholding
31st May 20164:44 pmRNSBlocklisting Six Monthly Return
26th May 20165:23 pmRNSResult of AGM
26th May 20167:00 amRNSAGM Statement
25th May 20167:00 amRNSABLS II Completes Drug Feasibility Programme
13th May 20167:00 amRNSDirector/PDMR Shareholding
10th May 20164:30 pmRNSLong Term Incentive Plan
28th Apr 201612:33 pmRNSHolding(s) in Company
26th Apr 20167:00 amRNSAllied Minds Raises $80m for ABLS Capital
25th Apr 20167:00 amRNSAnnual Financial Report
19th Apr 20167:00 amRNSAppointment of Joint Broker
16th Mar 20167:00 amRNSABLS agrees license with NYU
10th Feb 20164:40 pmRNSSecond Price Monitoring Extn
10th Feb 20164:36 pmRNSPrice Monitoring Extension
9th Feb 20164:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.